HomeRoche

  • Venclexta/Venclyxto improved overall survival in previously untreated AML patients

    • March 26, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche receives FDA’s breakthrough status for its new Alzheimer’s biomarker

    • July 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE rejects Ocrevus for PPMS, citing cost concerns

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE approves Ocrevus in RRMS but with certain conditions

    • June 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche announces long term disability data for Ocrevus in PPMS patients

    • June 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • GSK Appoints Senior Executive from Roche to Accelerate Pipeline Growth

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more